{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:quince-therapeutics-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","type":"Company","slug":"quince-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/quince-therapeutics-inc","legal_name":"Quince Therapeutics, Inc.","display_name":"Quince Therapeutics, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-10-03T04:46:56.448052+00:00","observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":"2026-10-03T04:46:56.448052+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/quince-therapeutics-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/quince-therapeutics-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/quince-therapeutics-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/quince-therapeutics-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/quince-therapeutics-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/quince-therapeutics-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":21,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":6,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":21,"corroborated_claims":0,"sources":6,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-10-03T04:46:56.448052+00:00","observed_at":"2026-10-03T04:46:56.448052+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:legal_name:1","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Quince Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Quince Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/quince-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-03T04:46:56.448052+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:entity_status:3","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/quince-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-03T04:46:56.448052+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:published_fact:4","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/quince-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-03T04:46:56.448052+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:5","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-j-senner-2","object_label":null,"object_source_name_forms":[],"value":"Christopher J. Senner: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Christopher J. Senner: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:6","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-a-lamond","object_label":null,"object_source_name_forms":[],"value":"David A. Lamond: Director, Compensation · Chair; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"David A. Lamond: Director, Compensation · Chair; Nominating and Governance · Chair","corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:7","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dirk-thye-m-d","object_label":null,"object_source_name_forms":[],"value":"Dirk Thye, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Dirk Thye, M.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:8","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:june-bray","object_label":null,"object_source_name_forms":[],"value":"June Bray: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"June Bray: Director, Audit","corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:9","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:luca-benatti-ph-d","object_label":null,"object_source_name_forms":[],"value":"Luca Benatti, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Luca Benatti, Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:10","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-a-mcloughlin-ph-d","object_label":null,"object_source_name_forms":[],"value":"Margaret A. McLoughlin, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Margaret A. McLoughlin, Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:11","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rajiv-patni-m-d","object_label":null,"object_source_name_forms":[],"value":"Rajiv Patni, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Rajiv Patni, M.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:12","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:una-ryan-obe-ph-d","object_label":null,"object_source_name_forms":[],"value":"Una Ryan, OBE, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Una Ryan, OBE, Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null}],"source_date":"2025-04-23","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:13","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brendan-hannah","object_label":null,"object_source_name_forms":[],"value":"Brendan Hannah: Chief Operating Officer, Chief Business Officer, and Chief Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Brendan Hannah: Chief Operating Officer, Chief Business Officer, and Chief Compliance Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:3","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:14","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:charles-ryan-ph-d","object_label":null,"object_source_name_forms":[],"value":"Charles Ryan, Ph.D.: President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Charles Ryan, Ph.D.: President","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:3","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:leadership_role:15","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dirk-thye-m-d","object_label":null,"object_source_name_forms":[],"value":"Dirk Thye, M.D.: Chief Executive Officer, Chief Medical Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Dirk Thye, M.D.: Chief Executive Officer, Chief Medical Officer and Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:3","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_record:16","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Christopher J. Senner; Members Christopher J. Senner (Chair); June Bray","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Christopher J. Senner","members":[{"display_name":"Christopher J. Senner","person_slug":"christopher-j-senner","is_chair":true},{"display_name":"June Bray","person_slug":"june-bray","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:4","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:17","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:christopher-j-senner","object_label":"Christopher J. Senner","object_source_name_forms":[],"value":"Christopher J. Senner: chair, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:christopher-j-senner","name":"Christopher J. Senner"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:4","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:18","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:june-bray","object_label":"June Bray","object_source_name_forms":[],"value":"June Bray: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:june-bray","name":"June Bray"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:4","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_record:19","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair David A. Lamond; Members David A. Lamond (Chair)","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"David A. Lamond","members":[{"display_name":"David A. Lamond","person_slug":"david-a-lamond","is_chair":true}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:5","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:20","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:david-a-lamond","object_label":"David A. Lamond","object_source_name_forms":[],"value":"David A. Lamond: chair, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:david-a-lamond","name":"David A. Lamond"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:5","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_record:21","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair David A. Lamond; Members David A. Lamond (Chair)","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"David A. Lamond","members":[{"display_name":"David A. Lamond","person_slug":"david-a-lamond","is_chair":true}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:6","source_type":"board_seats","title":"Nominating and Governance","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:22","subject_id":"alpha:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:david-a-lamond","object_label":"David A. Lamond","object_source_name_forms":[],"value":"David A. Lamond: chair, Nominating and Governance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:david-a-lamond","name":"David A. Lamond"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-03T04:46:56.448052+00:00","sources":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:6","source_type":"board_seats","title":"Nominating and Governance","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-03T04:46:56.448052+00:00","reviewed_at":"2026-10-03T04:46:56.448052+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/quince-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-03T04:46:56.448052+00:00","locator":null},{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:2","source_type":"sec_proxy","title":"Quince Therapeutics, Inc. DEF 14A 2025-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":"2025-04-23","retrieved_at":"2026-04-28T23:51:01.281+00:00","locator":null},{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:3","source_type":"sec_filing","title":"QNCX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526182255/qncx-20260424.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T07:20:33.884819+00:00","locator":null},{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:4","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null},{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:5","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null},{"id":"alpha:evidence:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:6","source_type":"board_seats","title":"Nominating and Governance","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm","source_date":null,"retrieved_at":null,"locator":null}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[{"claim_id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:17","payload":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:christopher-j-senner","name":"Christopher J. Senner"},"source_id":"board_seats"}},{"claim_id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:18","payload":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:june-bray","name":"June Bray"},"source_id":"board_seats"}},{"claim_id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:20","payload":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:david-a-lamond","name":"David A. Lamond"},"source_id":"board_seats"}},{"claim_id":"alpha:claim:company:1a789c6e-8aaa-4daf-906a-d18ff607bf90:committee_appointment:22","payload":{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:david-a-lamond","name":"David A. Lamond"},"source_id":"board_seats"}}]}